Neoplasia/BPH

	Androgen Receptor Pathway Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer Outside of Randomized Controlled Trials: A Systematic Review and Meta-Analysis of Prognostic Factors in Real-World Analyses. Clin Genitourin Cancer Miyajima K, Yanagisawa T, Miszczyk M, Inoue S, Roessler N, Matsukawa A, Urabe F, Mori K, Karakiewicz PI, Chlosta P, Kimura T, Shariat SF. PMID: 42191465 [PubMed - as supplied by publisher]
	Urinary pH and oncologic outcomes after bacillus Calmette-GuÃ©rin in non-muscle invasive bladder cancer: A retrospective cohort study. Actas Urol Esp (Engl Ed) Kayar K, Kayar R, Ozdemir BB, Karabay E, Tosun C, Ozturk MI, Yucebas OE. PMID: 42191064 [PubMed - as supplied by publisher]
	Neoadjuvant Durvalumab Â± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study. J Clin Oncol Thibault C, Bennamoun M, Fléchon A, Gravis G, Pouessel D, Combe P, Borchiellini D, Loriot Y, Laguerre B, Barthélémy P, Huillard O, Gross-Goupil M, Le Roy A, Jaffrelot L, Cancel M, Audenet F, Belhouari H, Kaci G, Lepicard E, Vernerey D, Henriques J, Oudard S. PMID: 42190158 [PubMed - as supplied by publisher]
	Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study. Prostate Asanuma H, Fujita N, Kato S, Kawashima Y, Shinohara M, Tabata R, Yoneyama F, Tanaka R, Oishi T, Miura H, Togashi K, Okita K, Horiguchi H, Tanaka T, Noro D, Suzuki Y, Sato S, Ohyama C, Hatakeyama S. PMID: 42190045 [PubMed - as supplied by publisher]
	TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma. Mol Carcinog Singh A, Lakkaniga NR. PMID: 42189826 [PubMed - as supplied by publisher]
	Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols. PLoS One Quarello P, Dandis R, Chowdhury T, Verschuur A, Brok J, Vujanic G, Vokuhl C, Collini P, Coulomb A, Serra A, Biasoni D, Flores P, Kager L, Segers H, Mali, Burman MM, Dos Reis Farinha NJ, Romerius P, Godzinski J, van Grotel M, Ramirez-Villar GL, De Camargo B, Furtwängler R, Al-Saadi R, Van Tinteren H, Graf N, Spreafico F, van den Heuvel-Eibrink M. PMID: 42189790 [PubMed - indexed for MEDLINE]
	Integrative advances in biomarker-driven prostate cancer management from genomic discovery to precision oncology. Discov Oncol Ramesh P, Shree L, Balraj AS. PMID: 42189429 [PubMed - as supplied by publisher]
	Perioperative hyperchloremia is associated with acute kidney injury in elderly patients undergoing bipolar plasmakinetic transurethral resection of the prostate: a prospective observational study. World J Urol Jia H, Zheng Q, Zhang L, Bai J, Wang G, Guo T, Jin Q, Lu Y, Dong Z, Wang Z. PMID: 42189243 [PubMed - indexed for MEDLINE]
	The Role of Artificial Intelligence in the Characterization and Outcome Prediction of Prostate Cancer: A Systematic Review. Tomography Aljoudi S, Khan A, Dajani I, Al-Ani M, Mina M, Baroudi D, Al-Saffar S, Aouadi S, Torfeh T, Hammoud R, Al Hammadi N, Yousef MS. PMID: 42188703 [PubMed - indexed for MEDLINE]
	MRI-Derived Biomarkers and Radiomic Signatures for Early, Dose-Dependent Evaluation of Prostate Cancer Radiotherapy: An Exploratory Study. J Imaging Bekou E, Mulita A, Koukourakis IM, Courcoutsakis N, Kotini A, Psatha E, Tsakaldimis G, Seimenis I, Koukourakis MI, Karavasilis E. PMID: 42188250 [PubMed]
	Ruptured Wilms Tumor: Clinical Features, Diagnostic Challenges, and Survival Outcomes. Curr Oncol Emadeldeen H, Ghandour K, Al-Shamaileh T, Ibrahimi AK, Sarhan N, Sultan I, Halalsheh H. PMID: 42187610 [PubMed - indexed for MEDLINE]
	Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications. Curr Oncol Narvel H, Ganiyani MA, Gulam Nabi A, Goyal A, Garje R, Srinivasan S, Ahmed H, Kilari D. PMID: 42187597 [PubMed - indexed for MEDLINE]
	Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis. Curr Oncol Khosh Kish E, Dvorani E, Saskin R, Wilton AS, Satkunasivam R, Aminoltejari K, Hird A, Berscheid K, Roy S, Morgan SC, Ong M, Jiang DM, Gotto GT, Shayegan B, Kulkarni GS, Breau RH, Lalani AA, Nguyen DD, Wallis CJD. PMID: 42187593 [PubMed - indexed for MEDLINE]
	Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progression. Cancer Biol Ther Zhong J, Deng Y, Qin X, Yang Q. PMID: 42187002 [PubMed - indexed for MEDLINE]
	Cognitive Fusion-Guided Transperineal Biopsy Leading to the Diagnosis of Early Prostate Adenocarcinoma After Repeated Negative Evaluations: A Case Report. Curr Health Sci J Radu MA, P, Droca, Vasile DF, Dr, Mitroi G, Mirea CS, Dr. PMID: 42186598 [PubMed]
	Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort study. BMC Urol Mofid B, Jafari A, Simforoosh N, Basiri A, Siavashpour M, Siavashpour Z, Zabihi MS, Ghajari M, Razzaghdoust A. PMID: 42185887 [PubMed - as supplied by publisher]
	Overdiagnosis in renal cancer: the hidden consequence of modern imaging. Int Urol Nephrol Vallecilla Valencia K, Garcia-Perdomo HA. PMID: 42185723 [PubMed - as supplied by publisher]
	ASO Author Reflections: Refining CT Heterogeneity Scoring to Improve Clear Cell Renal Cell Carcinoma Diagnosis in Small Renal Masses. Ann Surg Oncol Zhang W, Li X, Zhu X, Song X, Qu J. PMID: 42185708 [PubMed - as supplied by publisher]
	Impact of frailty on perioperative and oncologic outcomes after robotic radical prostatectomy: a multicenter study with competing risk analysis. J Robot Surg Rabie A, Dovey Z, Falavolti C, Papalia R, Signore S, Martini A, Marco MD, Balah A, Petitti T, Buscarini M, Zaytoun O. PMID: 42185689 [PubMed - indexed for MEDLINE]
	Multi-omics analysis reveals TM4SF19 as a diagnostic and prognostic biomarker in bladder cancer. Discov Oncol Aizezi X, Silafu B, Shi H, Huang J. PMID: 42185687 [PubMed - as supplied by publisher]

Articles 1 - 20 / 188123

Page 1 of 9407



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy